MYC and malignant colon neoplasm: These mechanisms were also confirmed in colon cancer cell-injected BALB/c nude mice, where AST administration (25–50 mg/kg BW; four weeks) inhibits the metastasis of colon cancer to the lung via the MYC/miR-29a-3p and miR-200a axis [162].